slotkoers
Andere beurzen
|
||
- EUR | - |
2022 | TCR2 Therapeutics benoemt Chief Business and Strategy Officer | MT |
2021 | Pfizer wil meer expertise in immuno-inflammatoire ziekten met de overname van Arena Pharmaceuticals voor $6,7 miljard | MT |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Deborah Baron
PSD | President | 55 | 17-11-21 |
Kathleen Large
CTO | Chief Tech/Sci/R&D Officer | 64 | 01-01-19 |
Andrew Muratore
BRD | Director/Board Member | - | 17-11-21 |
Jeff Settleman
PRN | Corporate Officer/Principal | - | - |
Aaron Schimmer
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Deborah Baron
PSD | President | 55 | 17-11-21 |
Andrew Muratore
BRD | Director/Board Member | - | 17-11-21 |
Bedrijfsgegevens
Trillium Therapeutics ULC
1055 West Georgia Street
V6E 3P3, Vancouver
+
http://www.trilliumtherapeutics.comSector
- Beurs
- Aandelen
- Koers TRIL
- Koers R5W
- Onderneming Stem Cell Therapeutics Corp.